Home
About Atom
Management Team
Advisory Board
Investors
Our Programs
Pipeline
Gout & Hyperuricemia
Acute Gout
News & Events
Contact Us
Our Pipeline
Best-in-Class, Oral Drugs for Inflammatory and Metabolic Diseases
Project
Lead Optimization
Pre-Clinical
Phase 1
Phase 2
Phase 3
ABP-671
URAT1 inhibitor(Lingolinurad)
Gout & Hyperuricemia
Chronic Kidney Disease
Refactory Gout
ABP-745
Acute Gout & Other Indications
ABP-6118
Xanthine Oxidase Inhibitor
Gout
ABP-431
Anticancer
Learn About ABP-671 for Chronic Gout
Learn About ABP-745 for Acute Gout